Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation (Q37733826)

22 August 2017

1 reference

title

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation (English)

1 reference

22 August 2017

1 reference

Cunming Duan

1

1 reference

22 August 2017

Hongxia Ren

series ordinal

2

1 reference

22 August 2017

Shan Gao

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

18 April 2010

1 reference

General and Comparative Endocrinology

22 August 2017

1 reference

22 August 2017

167

1 reference

22 August 2017

3

1 reference

22 August 2017

344-351

1 reference

Zebrafish insulin-like growth factor-I receptor: molecular cloning and developmental expression

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Effects of an Igf1 gene null mutation on mouse reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Role of insulin-like growth factors in embryonic and postnatal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Phenotypic expression of IGF binding protein transcripts in muscle, in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Mutations in the C-Terminal Part of Insulin-Like Growth Factor (IGF)-Binding Protein-1 Result in Dimer Formation and Loss of IGF Binding Capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The formation of skeletal muscle: from somite to limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Late effects of disturbed IGF signaling in congenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Use of mutagenesis to probe IGF-binding protein structure/function relationships.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Mutant mouse models of insulin-like growth factor actions in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Duplicated zebrafish insulin-like growth factor binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Structural biology of insulin and IGF1 receptors: implications for drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Zebrafish make a big splash

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor (IGF) signalling is required for early dorso-anterior development of the zebrafish embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Skeletal myogenesis: genetics and embryology to the fore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Proliferation precedes differentiation in IGF-I-stimulated myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Cellular actions of the insulin-like growth factor binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Beta cell expression of IGF-I leads to recovery from type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Unraveling insulin-like growth factor binding protein-3 actions in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated zebra fish insulin-like growth factor binding protein 1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Duplication and diversification of the hypoxia-inducible IGFBP-1 gene in zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Niche regulation of muscle satellite cell self-renewal and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The emerging biology of satellite cells and their therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Wiring diagrams: regulatory circuits and the control of skeletal myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Hypoxic gene expression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The somatomedin hypothesis: 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The insulin-like growth factor system and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-binding protein-3 plays an important role in regulating pharyngeal skeleton and inner ear formation and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Growth enhancement of transgenic mice expressing human insulin-like growth factor I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Structure, developmental expression, and physiological regulation of zebrafish IGF binding protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Somatic overgrowth associated with overexpression of insulin-like growth factor II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

MyoD family: a paradigm for development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Neural and head induction by insulin-like growth factor signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Resistance exercise: good for more than just Grandma and Grandpa's muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

IGF-I is required for normal embryonic growth in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

From insulin, retinoblastoma protein and the insulin receptor to a new model on growth factor specificity: the nucleocrine pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Gene duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insights from insulin-like growth factor binding protein transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like signaling, nutrient homeostasis, and life span

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The MyoD family and myogenesis: redundancy, networks, and thresholds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin signaling in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Selective control of skeletal muscle differentiation by Akt1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Insulin-like growth factor signaling in fish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Muscle basic helix-loop-helix proteins and the regulation of myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Tissue-specific inactivation of murine M6P/IGF2R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Perspectives in mammalian IGFBP-3 biology: local vs. systemic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Several acidic amino acids in the N-domain of insulin-like growth factor-binding protein-5 are important for its transactivation activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Duplication of the IGFBP-2 gene in teleost fish: protein structure and functionality conservation and gene expression divergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

Zebrafish IGF genes: gene duplication, conservation and divergence, and novel roles in midline and notochord development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

The adaptive potential of skeletal muscle fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2010.04.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGCEN.2010.04.009

1 reference

22 August 2017

1 reference